Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults

Abstract

Background There is limited evidence on sarcopenia in Asian populations. This study aimed to clarify the prevalence, associated factors, and the magnitude of association with mortality and incident disability for sarcopenia and combinations of its components among Japanese community‐dwelling older adults. Methods We conducted a 5.8 year prospective study of 1851 Japanese residents aged 65 years or older (50.5% women; mean age 72.0 ± 5.9) who participated in health check‐ups. Sarcopenia was defined according to the Asian Working Group for Sarcopenia 2019 algorithm. Appendicular lean mass index (ALMI) was measured using direct segmental multi‐frequency bioelectrical impedance analysis. A Cox proportional hazards regression model was used to identify associations of sarcopenia and the combinations of its components with all‐cause mortality and incident disability. Results The prevalence of sarcopenia was 11.5% (105/917) in men and 16.7% (156/934) in women. Significant sarcopenia‐related factors other than ageing were hypoalbuminaemia, cognitive impairment, low activity, and recent hospitalization (all P‐values <0.05) among men and cognitive impairment (P = 0.004) and depressed mood (P < 0.001) among women. Individuals with sarcopenia had higher risks of mortality [hazard ratios (95% confidence interval): 2.0 (1.2–3.5) in men and 2.3 (1.1–4.9) in women] and incident disability [1.6 (1.0–2.7) in men and 1.7 (1.1–2.7) in women]. Compared with the individuals without any sarcopenia components, those having low grip strength and/or slow gait speed without low ALMI tended to have an increased risk of disability [1.4 (1.0–2.0), P = 0.087], but not mortality [1.3 (0.8–2.2)]. We did not find increased risks of these outcomes in participants having low ALMI in the absence of low grip strength and slow gait speed [1.2 (0.8–1.9) for mortality and 0.9 (0.6–1.3) for incident disability]. Conclusions Japanese older men and women meeting Asian criteria of sarcopenia had increased risks of all‐cause mortality and disability. There were no significant increased risks of death or incident disability for both participants with muscle weakness and/or low performance without low muscle mass and those with low muscle mass with neither muscle weakness nor low performance. Further studies are needed to examine the interaction between muscle loss, muscle weakness, and low performance for adverse health‐related outcomes.

Relationship between Oral Hypofunction and Sarcopenia in Community-Dwelling Older Adults: The Otassha Study

“…The prevalence of sarcopenia in our study population was 18.6% overall, 9.7% among men, and 22.5% among women. The prevalence of sarcopenia in older Asians using AWGS2019 criteria has ranged from 16.4 to 22.8% overall, 11.5 to 21.8% among men, and 16.7 to 23.1% among women [ 42 , 43 , 44 ]. The prevalence of men in the present study was lower than that of previous reports.…”

Transgenic Expression of Bmp3b in Mesenchymal Progenitors Mitigates Age-Related Muscle Mass Loss and Neuromuscular Junction Degeneration

“…2021, 22, 10246 2 of 13 general health and is therefore one of the major determinants of a healthy life expectancy. A recent epidemiological study confirmed that sarcopenia is strongly associated with an increased risk of all-cause mortality and disability [1]. Since the population is rapidly aging globally, preventing sarcopenia is an important task for public health.…”

The Relationship between Sarcopenia and Respiratory Muscle Weakness in Community-Dwelling Older Adults

“…Interest in sarcopenia, the age-related loss of skeletal muscle mass and function, is growing considerably. A recent systematic review and meta-analysis reported that the prevalence of sarcopenia in community-dwelling older adults is 10% [ 1 , 2 , 3 ]. Sarcopenia is a disorder characterized by progressive and generalized loss of skeletal muscle mass and function, and it is associated with increased adverse outcomes such as physical disability, poor quality of life, and death [ 4 , 5 , 6 , 7 , 8 , 9 ].…”